Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
March 28, 2025
Transforming retinal disease management through diabetes care
Catherine M Lockhart, Mark R Barakat, Jeffrey D Dunn, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
February 11, 2025
Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe
Mark R Barakat, Henry M Kwong, Gelson Marcon, et al.
Ophthalmology Science
|
September 27, 2024
Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial
Mark R Barakat, David Brown, Allen Hu, et al.
Translational Vision Science & Technology
|
November 5, 2020
Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders
Chen-Rei Wan, Barry Kapik, Charles C Wykoff, et al.
The British Journal of Ophthalmology
|
February 6, 2021
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)
Christopher Ryan Henry, Milan Shah, Mark R Barakat, et al.
American Journal of Ophthalmology
|
November 6, 2021
Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema
Thomas A Ciulla, Barry Kapik, Mark R Barakat, et al.
The British Journal of Ophthalmology
|
March 13, 2021
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)
Rahul N Khurana, Pauline Merrill, Steven Yeh, et al.
JAMA Ophthalmology
|
November 24, 2021
Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map
Arshad M Khanani, Marco A Zarbin, Mark R Barakat, et al.
Retina (Philadelphia, Pa.)
|
March 9, 2023
RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence
Charles C Wykoff, Hidetaka Matsumoto, Mark R Barakat, et al.
Ophthalmology
|
March 8, 2003
Clinicopathologic effects of mutant GUCY2D in Leber congenital amaurosis
Ann H Milam, Mark R Barakat, Nisha Gupta, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Journal of Managed Care & Specialty Pharmacy
|
March 28, 2025
Transforming retinal disease management through diabetes care
Catherine M Lockhart, Mark R Barakat, Jeffrey D Dunn, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
February 11, 2025
Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe
Mark R Barakat, Henry M Kwong, Gelson Marcon, et al.
Ophthalmology Science
|
September 27, 2024
Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial
Mark R Barakat, David Brown, Allen Hu, et al.
Translational Vision Science & Technology
|
November 5, 2020
Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders
Chen-Rei Wan, Barry Kapik, Charles C Wykoff, et al.
The British Journal of Ophthalmology
|
February 6, 2021
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)
Christopher Ryan Henry, Milan Shah, Mark R Barakat, et al.
American Journal of Ophthalmology
|
November 6, 2021
Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema
Thomas A Ciulla, Barry Kapik, Mark R Barakat, et al.
The British Journal of Ophthalmology
|
March 13, 2021
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)
Rahul N Khurana, Pauline Merrill, Steven Yeh, et al.
JAMA Ophthalmology
|
November 24, 2021
Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map
Arshad M Khanani, Marco A Zarbin, Mark R Barakat, et al.
Retina (Philadelphia, Pa.)
|
March 9, 2023
RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence
Charles C Wykoff, Hidetaka Matsumoto, Mark R Barakat, et al.
Ophthalmology
|
March 8, 2003
Clinicopathologic effects of mutant GUCY2D in Leber congenital amaurosis
Ann H Milam, Mark R Barakat, Nisha Gupta, et al.
Page
of 3